Advisors Asset Management, Inc. - AMYLYX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Advisors Asset Management, Inc. ownership history of AMYLYX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$158,253
+25.1%
8,643
+47.4%
0.00%0.0%
Q2 2023$126,465
-7.2%
5,863
+26.2%
0.00%0.0%
Q1 2023$136,284
-5.5%
4,645
+19.0%
0.00%0.0%
Q4 2022$144,2903,9050.00%
Other shareholders
AMYLYX PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Alpha Wave Global, LP 853,262$18,404,86112.06%
Stonepine Capital Management, LLC 1,121,028$24,180,5748.72%
GREAT POINT PARTNERS LLC 968,795$20,896,9084.09%
Ghost Tree Capital, LLC 550,000$11,863,5003.92%
Perceptive Advisors 4,873,919$105,130,4333.04%
Altium Capital Management LP 185,000$3,990,4503.02%
Boxer Capital, LLC 2,084,000$44,9522.08%
SECTORAL ASSET MANAGEMENT INC 387,310$8,354,2771.39%
AlphaCentric Advisors LLC 108,000$2,329,5601.29%
EMERALD MUTUAL FUND ADVISERS TRUST 680,035$14,668,3550.80%
View complete list of AMYLYX PHARMACEUTICALS INC shareholders